Skip to content
Recall Observatory FDA recall evidence

Drug product

Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count bottle (NDC 0591-0737-05), Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA92880.

D-823-2013

July 19, 2013

Class III

Product summary

Firm
Watson Laboratories Inc
Event
Event 65747
Status
Terminated
Classification
Class III
Quantity
1,260 bottles
Official record key
drug-enforcement:D-823-2013

Official wording

Reason: Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.

Code information: Lot # a) 444971A, Exp 8/13; b) 444973A, Exp 8/13

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent